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Background: Nutrients, in particular the nitrogen source, activate TORC1 signaling in yeast.
Results: The nitrogen source stimulates a rapid, transient activation of TORC1. Preferred nitrogen sources result in sustained
TORC1 activity and growth via a mechanism dependent on glutamine accumulation and independent of the Gtr/Rag.
Conclusion: Nutrients activate yeast TORC1 via two distinct mechanisms.
Significance: Gtr/Rag is not the only mechanism to activate TORC1 in response to nutrients.
The evolutionary conserved TOR complex 1 (TORC1) acti-
vates cell growth in response to nutrients. In yeast, TORC1
responds to the nitrogen source via a poorly understood mech-
anism. Leucine, and perhaps other amino acids, activates
TORC1 via the small GTPases Gtr1 and Gtr2, orthologs of the
mammalian Rag GTPases. Here we investigate the activation of
TORC1 by the nitrogen source and how this might be related to
TORC1 activation by Gtr/Rag. The quality of the nitrogen
source, as defined by its ability to promote growth and gluta-
mine accumulation, directly correlateswith its ability to activate
TORC1 as measured by Sch9 phosphorylation. Preferred nitro-
gen sources stimulate rapid, sustained Sch9 phosphorylation
and glutamine accumulation. Inhibition of glutamine synthesis
reduces TORC1 activity and growth. Poor nitrogen sources
stimulate rapid but transient Sch9 phosphorylation. A Gtr1
deficiency prevents the transient stimulation of TORC1 but
doesnot affect the sustainedTORC1activity in response to good
nitrogen sources. These findings suggest that the nitrogen
source must be converted to glutamine, the preferred nitrogen
source in yeast, to sustain TORC1 activity. Furthermore, sus-
tained TORC1 activity is independent of Gtr/Rag. Thus, the
nitrogen source and Gtr/Rag activate TORC1 via different
mechanisms.
To avoid metabolic stress, unicellular organisms possess
finely tuned regulatory systems to ensure that cell growth and
replication are tightly coupled to nutrient availability (1). Nitro-
gen is an essential element required for synthesis of amino
acids, nucleotides, and other cellular components. The budding
yeast Saccharomyces cerevisiae can sense, take up, and assimi-
late several different nitrogen sources (N-sources) (2). Qualita-
tively better N-sources are assimilated before others. The qual-
ity of a N-source is generally defined by its ability (i) to sustain
core nitrogen metabolism and thus growth and (ii) to activate
or repress specific transcriptional programs thatmediate selec-
tive nitrogen assimilation (3). To maintain growth, N-sources
must sustain core nitrogenmetabolism that involves four inter-
connected enzymatic reactions with -ketoglutarate, gluta-
mate, glutamine, and ammonia as key metabolites (4). Gluta-
mine is considered the best N-source for yeast cells (4). In the
presence of exogenous glutamine as the N-source, yeast cells
grow and replicate at a high rate and maximally repress the
metabolic pathways required for utilization of other N-sources
(2, 5). Moreover, glutamine plays an essential role in anabolic
metabolism, in particular in purine and pyrimidine synthesis,
and in the biosynthesis of other amino acids after conversion to
glutamate. Amino acids other than glutamate and glutamine
can also serve as nitrogen sources but only by sustaining nitro-
gen core metabolism indirectly. These amino acids undergo
deamination, liberating free ammonia that can then be used for
glutamate or glutamine synthesis, or generate glutamate via
transamination (6). Depending on the amino acid, the remain-
ing carbon skeleton after deamination or transamination is
either fed into carbon metabolism or converted through the
Ehrlich pathway into fuse oils and secreted (7).
Metabolic adaptation to the nutritional environment is
achieved via complex transcriptional, translational, and post-
translational regulation, which relies on nutrient sensing and
signal transduction (8, 9). The target of rapamycin (TOR)2
pathway is a central regulator of cell growth in response to
nutrients (10, 11). TOR is an evolutionary conserved protein
kinase found in two highly conserved multiprotein complexes
termed TOR complex 1 (TORC1) and TORC2. TORC1 is
acutely sensitive to rapamycin and is activated by nutrients (12,
13). TORC1 couples nutrient sufficiency to growth by activat-
ing anabolic processes such as protein synthesis and ribosome
biogenesis and repressing catabolic processes such as
autophagy. Despite the many cellular functions in which
TORC1 is involved, few direct TORC1 targets are known. The
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best-characterized TORC1 direct target in yeast is Sch9, a
kinase belonging to the AGC kinase family also containing
PKA, PKG, and PKC. In the presence of nutrients, TORC1
phosphorylates at least six residues in the Sch9 C terminus and
thereby activates Sch9 in a rapamycin-sensitive manner (14–
16). Sch9 activates genes encoding ribosomal proteins and fac-
tors required for ribosome biogenesis (RiBi regulon) (17), ulti-
mately controlling cell growth and longevity (18–20).
In yeast the so-called EGOcomplex (EGOC)mediates amino
acid-dependent activation of TORC1 (21). EGOC consists of
Gtr1, Gtr2, Ego1, and Ego3. The small GTP binding proteins
Gtr1 and Gtr2 are orthologs of the mammalian RagA/B and
RagC/D GTPases, respectively (22–24). Like their mammalian
counterparts, Gtr1 and Gtr2 form a heterodimer that is active
in the Gtr1GTP-Gtr2GDP conformation. Ego1 and Ego3, the
functional homologs of the mammalian Ragulator complex
(25), are also required for activation of Gtr. The amino acid
leucine stimulates Gtr1GTP interaction with Ego1, thereby acti-
vating EGOC and, in turn, TORC1 (22). Vam6 and the Npr2-
Npr3-Iml1 complex were identified as the guanine nucleotide
exchange factor and GTPase-activating protein, respectively,
for Gtr1 (22, 26). The yeast leucyl-tRNA synthetase (LeuRS)
was reported to positively influence the GTP loading of Gtr1
(27).
The rapamycin-induced response in yeast mimics the
response to nitrogen starvation (28–30). This early observation
led to the conclusion that the N-source activates TORC1. The
mechanism by which the N-source, in the form of an amino
acid or other nitrogenous compound, activates TORC1 is
poorly understood. Early studies reported a prominent role for
the intracellular level of glutamine inTORC1 activation, at least
toward the transcription factors Gln3, Rtg1, and Rtg3 (31).
Although increasing evidence suggests that intracellular leu-
cine stimulates TORC1 via EGOC, it is not yet known if the
N-source, including ammoniumor other amino acids, activates
TORC1 via EGOC. Cells expressing a constitutively active ver-
sion of Gtr1 (Gtr1Q65L) still down-regulate TORC1 activity in
response to ammonium starvation (22), suggesting that the
N-source signals to TORC1 independently of Gtr1.
Here we investigate the modulation of TORC1 activity by
different N-sources in vivo using the phosphorylation state of
Sch9 as readout. We show that preferred N-sources sustain
TORC1 activity and growth rate by rapidly increasing gluta-
mine synthesis. Moreover, we demonstrate that glutamine syn-
thesis does not require Vam6 or Gtr1 for TORC1 activation.
Thus, there are distinct molecular mechanisms by which nutri-
ents activate TORC1.
EXPERIMENTAL PROCEDURES
Yeast Strains, Plasmid, and Media—Yeast strains and plas-
mids used in this study are listed inTable 1 and 2. Yeast cultures
were grown in flasks at 30 °C in liquid YMM containing only
one source of nitrogen at a final concentration of 0.5 g/liter.
Detailed composition of 1 liter YMM is as follows: 5 g of
(NH4)2SO4, 3 g of KH2PO4, 0.5 g of MgSO47H2O, 1.5 mg
of EDTA, 4.5 mg of ZnSO47H2O, 0.3 mg of CoCl26H2O, 1 mg
of MnCl24H2O, 0.3 mg of CuSO45H2O, 4.5 mg of
CaCl22H2O, 3mg of FeSO47H2O, 0.4mg of NaMoO42H2O, 1
mg of H3BO3, 0.1 mg of KI, 5 g of biotin, 100 g of calcium
pantothenate, 100 g of nicotinic acid, 2.5 mg of inositol, 100
g of pyridoxine; 20 g of p-aminobenzoic acid, 100 g of thi-
amine, 20 g/liter glucose, 0.5 g/liter N-source to 1 liter with 100
mM potassium hydrogen phthalateH2O, pH 5.
Growth Conditions and Cell Extracts—Typically cells were
grown in YMM supplemented with the first N-source at a con-
centration of 0.5 g/liter in shaking flasks at 30 °C until mid log
phase (A600  1.0). In the case of nutrient upshift, the second
N-sourcewas added at time point 0 at the final concentration of
0.5 g/liter directly in the media. When performing nutrient
downshifts, cells were gently pelleted by spinning for 2 min at
1000 g and re-suspended at time point 0 in fresh YMMmedia
containing L-glutamine at the final concentration of 0.5 g/liter.
For each time point, 9 ml of culture were taken, quenched with
cold trichloroacetic acid (10% final concentration), and incu-
bated on ice for 5 min. Cells were then pelleted at 3500 g for
5min,washed twicewith cold acetone, anddried in a SpeedVac.
The cellular pellet was resuspended in 100 l of urea buffer (50
mM Tris-HCl, pH 7.5, 5 mM EDTA, 6 M urea, 1% SDS) and
mixedwith 200l of glass beads. Cell lysis was performed using
a bead-beater (Biospec Products), beating 5 times for 45 s at
maximum speed with 3 min intervals on ice. The extract was
collected and heated to 65 °C for 10 min. Unbroken cells and
debris were removed by centrifugation at 13,000 g for 5 min.
Protein concentration was determined using the Pierce BCA
protein assay (Thermo Fisher Scientific, Rockford, IL).
Chemical Fragmentation and Phosphorylation Quantifica-
tion of Sch9—Cell extracts were subjected to 2-nitro-5-thiocya-
natobenzoic acid (NTCB) cleavage as described previously (16).
Further analysis was done by SDS-PAGE and immunoblotting
using anti-HA antibody (HA-tag (6E2) mouse mAb #2367, Cell
Signaling Technology, Danvers, MA). To quantify Sch9 phos-
phorylation, we used the software ImageJ (32). We measured
the integrated density of the uppermost band (phosphorylated
protein) and divided it by the sum of the integrated density of
TABLE 1
Strains used in this study
Strain Genotype Source
YSBN9 MAT FY3 ho::Ble ura3-52 Canelas et al. (40)
YSBN9
vam6
MAT FY3 ho::Ble ura3-52
VAM6::KanMX
This study
YSBN9
gtr1
MAT FY3 ho::Ble ura3-52
GTR1::KanMX
This study
YSBN9
gtr2
MAT FY3 ho::Ble ura3-52
GTR2::KanMX
This study
YSBN9
DOT6-3HA
MAT FY3 ho::Ble ura3–52
DOT6-3xHA::KanMX
This study
TABLE 2
Plasmids used in this study
Plasmid Vector; insert Source
pRS416 cen URA3
pJU733 pRS416; cen URA3
SCH9-3xHA
Urban et al. (16)
pMB1393 YCplac33; cen URA3
Tet-on-GTR1
Binda et al. (22)
pMB1394 YCplac33; cen URA3
Tet-on-GTR1-Q65L
Binda et al. ( 22)
pMB1395 YCplac33; cen URA3
Tet-on-GTR1-S20L
Binda et al. (22)
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the uppermost plus the lowermost band (unphosphorylated
protein).
Metabolite Extraction—All samples were supplementedwith
50 l of 13C-labeled internal standard and extracted one time
with 1 ml of 75%(v/v) ethanol buffered with 10 mM ammonium
acetate, pH 7.5, at 78 °C for 3 min. After the extraction step
biomass was separated by centrifugation for 3 min at 5000 rpm
at 9 °C. The liquid extract of each sample was dried at 101
mbar to complete dryness in a RapidVac and then stored at
80 °C until resuspension.
Metabolite Mass Spectrometry—Liquid chromatography
separation of compounds was achieved by an ion pairing-re-
verse phase method developed for ultra high performance liq-
uid chromatography Q3 systems (33) based on previously pub-
lished high pressure methods (34–36) and implemented on a
Waters Acquity UPLC (Waters Corp., Milford, MA) using a
Waters Acquity T3 end-capped reverse phase column with
dimensions 150 2.1 mm 1.8 m (Waters Corp.). Selective
and sensitive detection of compoundswas achieved by coupling
liquid chromatography to a Thermo TSQ Quantum Ultra
QQQmass spectrometer from Thermo Fisher Scientific (Wal-
tham, MA) using a heated electrospray ionization source. The
mass spectrometer was operated in negative mode with
selected reaction monitoring. Fragmentation parameters were
optimized individually for all compounds (33). Both acquisition
and peak integration were performed with the Xcalibur soft-
ware Version 2.07 SP1 (Thermo Fisher Scientific). Peak areas
were normalized to fully 13C-labeled internal standards (37)
and the amount of biomass.
RESULTS
TORC1 Rapidly Phosphorylates Sch9 in Response to the
Nitrogen Source—We initially sought to establish a system
using the phosphorylation state of the Sch9 C terminus as a
readout to monitor changes in TORC1 activity in response to
nutrients in vivo. Moreover, we reasoned that signaling events
associated with nutrient availability would be triggered very
rapidly, as in the case of glucose-induced cAMP production in
yeast cells (38, 39). To capture fast-acting signaling events, Sch9
phosphorylation was assayed as early as 20 s and up to 4 h after
stimulation with nutrients. We used the strain YSBN9 (40),
which we made prototrophic by transformation with the cen-
tromeric plasmid pSCH9-3HA containing the selectable
marker URA3 in addition to expressing C-terminally 3HA-
tagged Sch9 under the control of its own promoter. By working
with a prototrophic strainwewere able to grow cells inmedium
supplemented with a single nitrogen source, thereby avoiding
the confounding effect of the simultaneous presence of differ-
ent N-sources.
We first validated our system by pharmacologically inhibit-
ing TORC1. Rapamycin treatment of yeast cells, grown in the
presence of glutamine, resulted in an acute decrease in Sch9
C-terminal phosphorylation. Compared with untreated cells,
Sch9 phosphorylation decreased tominimal levels within 5min
and remained low for the remainder of the experiment (Fig. 1,A
andB).Wenext sought to determine the effect of changes in the
nutritional environment on TORC1 activity by varying the
quality of nutrients from good to poor (nutrient downshift) or
from poor to good (nutrient upshift). When performing nutri-
ent downshift experiments, cells were grown in the presence of
the preferred N-source glutamine and switched to medium
containing a less preferred N-source such as proline. As
observed for rapamycin treatment, Sch9 phosphorylation
decreased to minimal levels within minutes after nutrient
downshift (Fig. 1, C andD). These data underscore the similar-
ity between pharmacological and physiological inhibition of
TORC1. In the case of nutrient upshift experiments, cells were
grown in the presence of proline and stimulated with a good
N-source. When using glutamine as the good N-source, Sch9
phosphorylation levels increased2-fold already within 1 min
after the addition of glutamine (Fig. 1, E and F). After this initial
increase, Sch9 phosphorylation decreased to rise again at 15
min. Pretreating cells with rapamycin for 10 min was sufficient
to block the increase in Sch9 phosphorylation induced by glu-
tamine (Fig. 1G), demonstrating that Sch9 was phosphorylated
by TORC1 during the nutrient upshift. To determine whether
the increase in Sch9 phosphorylation was caused exclusively by
the presence of the newly introduced N-source, we performed
mock upshift experiments without increasing the nitrogen
quality. As expected, no increase in Sch9 phosphorylation was
observed when cells were treated with water or the same
medium in which they were growing (Fig. 1, H and I). Overall,
these findings indicate that our in vivo system is valid and that
the N-source rapidly stimulates TORC1 activity.
The Quality of the Nitrogen Source Determines TORC1
Activity—To gain mechanistic insight into the nutrient-in-
duced activation ofTORC1,we quantified the extent of TORC1
activity over time in response to different N-sources.We deter-
mined the dynamics of Sch9 phosphorylation during nutrient
upshift experiments in response to various nitrogen sources
including growth-promoting amino acids and ammonium (Fig.
2). All N-sources tested induced a rapid increase in Sch9 phos-
phorylation within 20 s and peaking at 2–3 min after stimula-
tion, although with different amplitudes. As observed above for
glutamine, this rapid increase was transient as Sch9 phosphor-
ylation then decreased, often to near basal levels. Upon com-
paring the change in Sch9 phosphorylation at 30 min and up to
4 h after shift, theN-sources clustered into two discrete groups.
The first group contained the so-called high-end N-sources,
able to re-stimulate and sustain highTORC1 activity (p 0.05).
The second group contained the low-end N-sources where
Sch9 phosphorylation remained low (Fig. 2A). Arginine, aspar-
agine, glutamine, and ammonium belonged to the high-end
N-sources (Fig. 2B). Serine, threonine, the branched chain
amino acids (isoleucine, leucine, and valine), the negatively
charged amino acids (aspartate and glutamate), and the hydro-
phobic amino acids (alanine, methionine, phenylalanine, and
tryptophan) fell in the low-end group (Fig. 2C). Tyrosine was
not included in the study because of its low solubility in water.
All the N-sources belonging to the high-end group were previ-
ously characterized as preferred N-sources (3). Similarly, the
N-sources belonging to the low-end group were previously
classified as less preferred, with the exception of alanine, serine,
aspartate, and glutamate. We conclude that sustained TORC1
activity after nutrient upshift correlates with the quality of the
N-source.
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We next asked whether the quality of the initial N-source
would affect the extent of TORC1 stimulation upon nutrient
upshift. To this end we compared the ability of glutamine and
ammonium, two preferred N-sources, to stimulate TORC1
activity in cells initially grown in the presence of proline or
leucine, an intermediate and a non-preferredN-source, respec-
tively.Weobserved that the glutamine- or ammonium-induced
increase in Sch9 phosphorylation was equal in cells originally
grown in the presence of proline or leucine as the onlyN-source
(data not shown). Therefore, TORC1 activity is solely depen-
dent on the quality of the N-source added during nutrient
upshift. Collectively, we conclude that the extent of TORC1
stimulation in vivo parallels the quality of the N-source. In gen-
eral, preferred N-sources stimulate and sustain TORC1 activ-
ity, whereas poor N-sources do not.
The Quality of the Nitrogen Source Couples TORC1 Activa-
tion to Cell Growth—Phosphorylation of Sch9 influences its
kinase activity in vitro and in vivo (16, 17). We next asked
whether the Sch9 phosphorylation increase observed during
nutrient upshift would result in increased Sch9 kinase activity.
Tomonitor Sch9 kinase activity in vivo, wemeasured the phos-
phorylation state of Dot6, a direct target of Sch9 involved in
ribosome biogenesis (17). As assayed by immunoblotting,
nutrient upshifts with glutamine, leucine, or ammonium
resulted in the appearance of a slow-migrating form of C-ter-
minally 3HA-tagged Dot6 (Fig. 3A). As expected, no detect-
able change in Dot6 phosphorylation was observed when
supplementing cells with water (Fig. 3A). In all three nutrient
upshift experiments, Dot6 phosphorylation increased
already at 2–3 min after stimulation, consistent with the
rapid increase in Sch9 phosphorylation described above.
Interestingly, Dot6 phosphorylation was sustained up to 30
min after stimulation with the preferred N-source glutamine
or ammonium, whereas Dot6 phosphorylation decreased
starting at 8 min after shifting to the less preferred N-source
leucine. For unknown reasons, shift to leucine also caused a
FIGURE1.TORC1 rapidlyphosphorylatesSch9 in response to thenitrogensource.Sch9C-terminal phosphorylationdecreasedupon rapamycin treatment
(200 nM) (A and B) and during nutrient downshift (glutamine to proline) (C andD).D and E, Sch9 C-terminal phosphorylation increased during nutrient upshift
(proline to glutamine). Sch9 phosphorylation was unaffected when cells were subjected to either nutrient upshift (Pro to Gln) after rapamycin pretreatment
(200 nM, 10 min; G) or mock-treated with water (H) or with the same medium in which they were growing (I). Protein samples were chemically cleaved with
NTCB. Electrophoretic mobility shift was induced by the Sch9 C-terminal phosphorylation state, assessed by Western blot (panel A, C, E, G, H, and I). Relative
quantification of Sch9 C-terminal phosphorylation (panel B, D, and F) is expressed as the mean S.E. of at least three independent biological experiments.
TORC1 Activation by Nitrogen Source
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decrease in Dot6 protein levels at 30 min after the shift.
These data suggest that nutrient stimulation rapidly acti-
vates Sch9 downstream of TORC1.
Active Sch9 positively regulates ribosome biogenesis,
thereby increasing cell growth potential (16, 41). We tested the
physiological impact of TORC1 activation upon nutrient
TORC1 Activation by Nitrogen Source
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upshift on cell growth. Yeast cells grown in the presence of
proline were supplemented with glutamine, ammonium, leu-
cine, or water (Fig. 3B). After glutamine or ammonium stimu-
lation, growth increased within 2–3 h after treatment com-
pared with unstimulated cells. The observed increase in growth
rates paralleled sustained Sch9 and Dot6 phosphorylation up
to 4 h after treatment (Fig. 3, C and D). Conversely, growth
rate was unaffected when cells were supplemented with leu-
cine or water, and Sch9 and Dot6 phosphorylation remained
low. Thus, stimulation with preferred N-sources confers an
increase in TORC1 activity and a corresponding increase in
proliferation.
Intracellular Glutamine Is a Metabolic Input to Activate
TORC1—Asdescribed above, prolonged stimulation ofTORC1
by preferred N-sources correlates with increased growth rate.
These data suggest that the transient TORC1 activation elicited
in the first minutes of nutrient upshift, common to all
N-sources tested, is not sufficient to maintain growth. We
FIGURE 2. The quality of the nitrogen source determines TORC1 activity.N-sources can be grouped based on the increase in Sch9 C-terminal phosphory-
lation upon nutrient upshift. A, classification of the N-sources based on their ability to sustain TORC1 activity for up to 4 h after shift. The -fold change mean
valueS.D. of Sch9phosphorylationat fivedifferent timepoints (30, 60, 120, 180, and240minafter shift) for eachN-source is shown in thegraph. For statistical
analysiswe compared in a two-way analysis of variance analysis the values of these five timepoints for eachN-source to the respective values obtained inmock
shift experiments with water. In four cases (Arg, Asn, Gln, and NH4
	) the difference was significant (p  0.05). B, -fold change of Sch9 C-terminal relative
phosphorylation after nutrient upshift from proline to individual high-end N-sources (arginine, asparagine, glutamine, and ammonium). Relative quantifica-
tions are expressed as themean S.E. of at least three independent biological experiments. C, -fold change of Sch9 C-terminal relative phosphorylation after
nutrient upshift fromproline to individual low-endN-sources (alanine, aspartate, glutamate, isoleucine, leucine,methionine, phenylalanine, serine, threonine,
tryptophan, and valine). Relative quantifications are expressed as the mean S.E. of at least three independent biological experiments.
FIGURE3.Thequalityof thenitrogen source couplesTORC1activation to cell growth. Sch9 is activated after nutrient upshift.A, thephosphorylationof the
Sch9 direct target Dot6 increases during nutrient upshift from proline to glutamine, leucine, and ammonium but not when treating cells with water. A
representativeWestern blot of protein extracts is shown. The red line indicates the fastmigratingbandofDot6,which corresponds to the hypophosphorylated
form. B, cell growth is increased after glutamine and ammonium upshift but not when using leucine or in cells treated with water. A representative growth
curve of three independent replicates is shown. Increased phosphorylation of Sch9 C terminus (C) and Dot6 correlate (D) with the N-source induced increased
in cell growth.
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tested this hypothesis by titrating the concentration of gluta-
mine used for the nutrient upshift and monitoring the effects
on Sch9 phosphorylation and growth rate. Indeed, a lower final
concentration of glutamine (5mg/liter, Gln 1%) was still able to
rapidly induce TORC1 activity but failed to sustain Sch9 phos-
phorylation over time (Fig. 4, A and B). The low glutamine
concentration also failed to enhance the growth rate of cells
grown on proline, whereas an intermediate concentration of
glutamine (50 mg/liter, Gln 10%) only partially increased
growth (Fig. 4C). In conclusion, low concentrations of gluta-
mine, unable to sustain TORC1 activity over time and conse-
quently growth, still trigger an early activation wave of TORC1.
The above data suggest two distinct mechanisms for how
N-sources stimulate TORC1. The first mechanism, respon-
sible for the rapid, transient activation of TORC1, is trig-
gered by all N-sources independent of quality and is unable
to sustain growth. The second mechanism, in response to
good N-sources, mediates sustained TORC1 activity and
growth. The sustained stimulation of TORC1 could be depen-
dent on a “metabolic input” that a poor N-source is not able to
generate or maintain. To investigate the nature of a potential
metabolic input, we measured the changes in relative levels of
several metabolites by mass spectrometry, focusing on the first
10 min after nutrient upshift. We reasoned that if a common
metabolic input exists, its relative level would increase/de-
crease within the first minutes after nutrient upshift and upon
reaching a certain threshold would sustain TORC1 activity and
growth. We consistently found that the intracellular level of
glutamine increased in cells stimulated with a preferred
N-source such as ammonium, asparagine, or glutamine itself
FIGURE 4. Intracellular glutamine constitutes ametabolic input to activate TORC1. The increase in cell growth rate after nutrient upshift depends on the
quality and quantity of the given N-source. A and B, nutrient upshift with 1% glutamine (final concentration 5 mg/liter) results in low Sch9 C-terminal
phosphorylation at 30 min after shift compared with nominal (100%) glutamine concentration (final concentration 0.5 g/liter). Relative Sch9 C-terminal
phosphorylation quantification is expressed as themean S.E. C, cell growth rate with different N-sources at different concentrations. Where not specified or
when 100%, the final concentration of the N-source was 0.5 g/liter. The black arrow indicates the time of stimulation. A representative growth curve of three
independent replicates is shown. Glutamine synthesis and accumulation within the first 10 min after nutrient upshift are key features of high-end, preferred
N-sources. Shown are intracellular glutamine levels measured by LC-MS/MS during nutrient upshifts with ammonium (D), asparagine (E), leucine (F), and
glutamine (G) at the final concentration of 0.5 g/liter (100%) and glutamine (H) at the final concentration of 5mg/liter (glutamine 1%). -Fold changes of relative
glutamine levels are expressed as the mean S.E.
TORC1 Activation by Nitrogen Source
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(Fig. 4D, E, G, and H). Interestingly, glutamine levels increased
2-fold already within 2 min after ammonium and asparagine
addition, but remained below the 2-fold threshold for up to 9
min after the addition of leucine (Fig. 4F). When stimulating
with a lower amount of glutamine (1%), we observed a corre-
sponding smaller and transient increase of intracellular gluta-
mine (Fig. 4H). These data suggest that intracellular glutamine
may be the common metabolite required for TORC1
activation.
Next we investigated the role of glutamine synthesis in
TORC1 activation during nutrient upshift. To this end we used
the drug methionine sulfoximine (MSX), a specific inhibitor of
glutamine synthetase. MSX treatment of cells growing in glu-
tamine-free media leads to an arrest in cell growth due to
decreased intracellular glutamine levels and decreased TORC1
signaling (31). As previously reported,MSX treatment compro-
mised cell grown in the presence of ammonium or leucine but
not in the presence of glutamine (data not shown). We tested
the effect of blocking glutamine synthesis on activation of
TORC1by treating cells for 1 hwithMSXbefore the addition of
an N-source. Pretreatment with MSX prevented Sch9 phos-
phorylation when stimulating with leucine or ammonium (Fig.
5, D and E.). When stimulating with ammonium, Sch9 phos-
phorylation was significantly impaired in both the initial and
delayed phases of TORC1 activation (p 0.01) (Fig. 5D). MSX
decreased the transient stimulation observed with leucine (p
0.05) (Fig. 5E). However, no significant difference in the
increase in Sch9 phosphorylation was observed in cells stimu-
lated with glutamine (Fig. 5F). These data suggest that ammo-
nium assimilation into glutamine is essential for ammonium to
be sensed and translated into the metabolic input activating
TORC1.We conclude that the intracellular level of glutamine is
important for TORC1 activation by the N-source. Intracellular
accumulation of glutamine constitutes a metabolic input for
TORC1 activation in response to a good N-source.
The Metabolic Input Acts Independently of Gtr/Rag in
TORC1 Activation—Next, we addressed the mechanism by
which the N-source activates TORC1 and how this is related to
amino acid-dependent activation of TORC1. Leucine and pos-
sibly other amino acids activate TORC1 via EGOC (see the
Introduction), whereas themechanism of TORC1 activation by
N-sources such as ammonium and glutamine is unknown. To
address the role of EGOC in TORC1 signaling during N-source
upshift, we examined glutamine stimulation in strains lacking
GTR1 orVAM6. Glutamine failed to stimulate rapid Sch9 phos-
phorylation in gtr1 and vam6 strains but was still able to
induce the delayed, sustained Sch9 phosphorylation (Fig. 6, A
and B). The delayed Sch9 phosphorylation in the deletion
strains was comparable with that observed in a wild-type strain
(Fig. 6,A and B).We also tested the effect of inhibitingGtr1 using
1,3-dihydro-1-hydroxy-2,1-benzoxaborole (DHBB). DHBB occu-
pies the editing site in LeuRS, inhibiting the interaction of LeuRS
with Gtr1 and favoring hydrolysis of Gtr1-bound GTP (27).
DHBB pretreatment had no effect on Sch9 phosphorylation
after glutamine stimulation but decreased TORC1 activation
upon stimulation with leucine (Fig. 6, C–F). These data are
consistent with a positive role for EGOC in the rapid, transient
activation of TORC1 and at the same time suggest that gluta-
mine accumulation is able to stimulate and sustain TORC1
activity even in the absence of a functional EGOC. Moreover,
LeuRS appears to play a role in the specific activation of TORC1
by leucine and is dispensable for the N-source input.
To further investigate the requirement of EGOC for growth,
we compared growth of a wild-type and several EGOC mutant
strains on solid YMMmedia supplementedwith only one nitro-
gen source. We used vam6, gtr1, and gtr2 strains and
strains in which we complemented GTR1 loss by ectopically
expressing wild-type GTR1 or allelic versions of GTR1 encod-
ing inactiveGDP-bound (GTR1S20L) or activeGTP-boundGtr1
(GTR1Q65L). Strains lacking GTR2 grew worse than other
EGOC-deficient strains (Fig. 6G), indicating a dominant role
for GTR2 over GTR1 as previously reported (22). This may be
FIGURE5.MSXtreatmentblocks themetabolic input toTORC1.Glutamine
synthesis and accumulation constitute a metabolic input signal to TORC1.
MSX pretreatment (2 mM, 1 h) reduced the Sch9 C-terminal phosphorylation
increase during nutrient upshift with ammonium (A) and leucine (B) but not
when using glutamine (C). Relative quantifications are expressed as the
mean  S.E. Statistical analysis was performed using two-way analysis of
variance.
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due to a more prominent role of Gtr2 in permease sorting,
although both GTR2 and GTR1 were reported to be required
for the plasma membrane sorting of Gap1 and Put4 (42). Con-
sistent with this explanation, we found that the gtr2 strain
failed to grow on proline as the sole N-source. Conversely, the
gtr1 strain was viable on proline medium (Fig. 6G), indicating
that at least in our background (S288c-derived prototroph)
Gtr1 is not required for permease sorting to the plasma mem-
brane. Deletion of GTR1 negatively affected growth only when
cells were forced to use leucine as the sole N-source.GTR1was
dispensable for growth in the presence of the preferred
N-source glutamine or ammonium (Fig. 6G). Expression of
wild-type or constitutively active Gtr1 restored growth of gtr1
cells on leucine. Expression of inactive GDP-bound Gtr1 fur-
ther impaired growth on leucine but had no remarkable effect
when cells were grown in the presence of glutamine or ammo-
nium (Fig. 6G). Also, growth of a vam6 strain was rescued in
the presence of glutamine or ammonium.When grown on pro-
line or leucine, a vam6 strain displayed a phenotype interme-
diate to that exhibited by gtr1 and gtr2 strains (Fig. 6G),
suggesting a role for Vam6 in growth regulation in addition to
its role as a guanine nucleotide exchange factor for Gtr1. We
conclude that preferred N-sources, such as glutamine and
ammonium, sustain growth independently of Gtr/Rag, whereas
cells cultured in the presence of leucine as the only N-source
require functional Gtr/Rag.
The EGOC components Gtr2, Ego1, and Ego3 were initially
identified as necessary for restoration of growth after rapamy-
cin treatment (43). Indeed, we found that vam6, gtr1, and
gtr2 strains, independently of the N-source, were unable to
FIGURE 6. The metabolic input acts independently of the EGO complex in TORC1 activation. A and B, after glutamine upshift, only the rapid, transient
increase in Sch9 C-terminal phosphorylation is impaired in the vam6 and gtr1 strains comparedwith wild type. DHBB pre treatment (10M, 30min) has no
effect on Sch9 phosphorylation after glutamine upshift (C andD), whereas it affects TORC1 activation in response to leucine stimulation (E and F). Western blot
ofNTCB-treated samples (panel A,C, and E) and relativequantifications are expressedas themean S.E. (panel B,D, and F).G, growthassayonYMMsolidmedia
containing the indicatedN-sources at the final concentration of 2.5mg/ml. In the lower panel, cells were plated after rapamycin treatment (200 nM, 6 h). All the
indicated strains were initially grown in YMM supplemented with ammonium at the final concentration of 0.5 g/liter and spotted on solid media after serial
dilutions (1:5) starting at A600 of 0.2.
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resume growth after rapamycin treatment (Fig. 6G, lower
panel). In the gtr1 strain, growthwas restored by expression of
wild-type as well as constitutively active Gtr1. These data sug-
gest that EGOC is essential for restoration of growth after rapa-
mycin treatment independent of the nutritional environment.
Overall, we show that glutamine activates TORC1 indepen-
dently of Gtr/Rag.
DISCUSSION
Here we investigated in vivo activation of TORC1 by
N-sources and whether the underlying molecular mechanism
requiresGtr/Rag. Both high (glutamine or ammonium) and low
quality (leucine) N-sources stimulated a rapid, transient activa-
tion of TORC1 in aGtr/Rag-dependentmanner. However, only
high quality N-sources sustained TORC1 activity and growth.
The preferred N-sources ultimately sustained TORC1 activity
via glutamine synthesis and/or accumulation. Intracellular glu-
tamine sustained TORC1 activity independently of Gtr/Rag.
These findings suggest that nutrients activate TORC1 via dif-
ferent molecular mechanisms and explain why Gtr/Rag is not
essential for TORC1 signaling or viability in the presence of
preferred N-sources.
Several observations support our suggestion that Gtr/Rag is
not the only mechanism of TORC1 activation by nutrients.
First, constitutively active GTP-boundGtr1 is unable to sustain
TORC1 activity after ammonium starvation (22). Second,
mutations that likely increase the intracellular levels of gluta-
mine suppress the inability of EGOCmutants to resume growth
after rapamycin treatment (43). Third, we show that glutamine
but not leucine sustains growth of vam6 and gtr1 strains defec-
tive in EGOC function. Fourth, we also show that EGOC is
required for an initial, transient stimulation of TORC1 in
response to all examined nutrients but is not required for sus-
tained TORC1 signaling in response to a good N-source. Thus,
a good N-source such as glutamine activates TORC1 via a
mechanism independent of EGOC. The decrease in Sch9 phos-
phorylation between the transient and sustained peaks of
TORC1 activity might reflect the alternate onset of the EGO-
and the glutamine-dependent mechanisms of TORC1 activa-
tion. The mechanism by which glutamine activates TORC1 in
the absence of EGOC remains to be determined.
In mammalian cells two models have been proposed to
explain how amino acids influence the GTP loading of Rags. In
one model, amino acids stimulate RagA/BGTP by a so-called
lysosomal inside-out mechanism dependent on the vacuolar
ATPase but independent of a proton gradient (44). In a second
model glutamine and leucine stimulate glutaminolysis and
thereby-ketoglutarate production that enhancesGTP loading
of RagA/B, which ultimately activates mTORC1 (45, 46). Strik-
ingly, in yeast, glutamine synthesis and accumulation, rather
than glutaminolysis, positively regulate TORC1 activity. This
may reflect themetabolic differences betweenmammalian cells
and budding yeast. In proliferating mammalian cells, ATP is
produced mainly via mitochondrial oxidative phosphorylation.
In this case the flux through the TCA cycle is required to
replenish the NADH pool to maintain respiration. Thus, in
mammalian cells, the equilibrium-ketoglutarate7 glutamate
7 glutamine is pushed to the left, requiring -ketoglutarate to
sustain high flux through theTCAcycle (47). Conversely, expo-
nentially growing Saccharomyces cerevisiae providedwith a fer-
mentable sugar favor glycolysis over respiration even in aerobic
conditions and even though glycolysis is less efficient at pro-
ducing ATP (48, 49). Glucose also affects the expression of
genes involved in nitrogen metabolism, such as the NADP-de-
pendent glutamate dehydrogenase encoding genes GDH1 and
GDH3 (9, 50). In the presence of glucose, GDH1 is highly
expressed and accounts for the reductive amination of -keto-
glutarate to glutamate. Thus, glutamate levels are kept high in
the presence of glucose, but ammonium is then required to
convert glutamate to glutamine. In this situation, ammonium is
limiting for growth (51). Preferred N-sources such as ammo-
niumor glutamine, by favoring glutamine synthesis or accumu-
lation, provide a richer nutritional environment leading to
increased TORC1 signaling and faster growth. Non-preferred
N-sources, unable to drive glutamine synthesis and accumula-
tion, result in lower TORC1 activation and slower growth.
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